Tarena International (NASDAQ:TEDU) reported quarterly earnings of $0.34 per share. This is a 128.33 percent increase over losses of $(1.20) per share from the same period last year. The company reported $90.40 million
Exelixis Inc (NASDAQ:EXEL) announced detailed results from the COSMIC-313 Phase 3 trial cabozantinib (Cabometyx), nivolumab, and ipilimumab combo in untreated advanced…